Stocks to Buy Today - Stock Message Board, Discussion Forum, Blog

OTC Showcase Male Walton, KY United States: Like

0 members like this; Share Twitter

Blog Posts (4)
Discussions (18)
Groups

OTC Showcase's Friends

View All

OTC Showcase's Discussions

Nuvilex Reports Positive Phase 2 Data for Pancreatic Cancer Treatment; $0.50 Price Target
2 Replies

Tags: treatments, cancer, drugs, biotechnology, stocks

Started this discussion. Last reply by Kendawg Jun 3, 2011.

Misonix, Inc.: IP Award and New Targets of Opportunity

Misonix (NASDAQ: MSON; Stock Twits: $MSON) recently presented at the MDB Capital Bright Lights Conference in New York City -- the only conference of its kind with an exclusive focus on…Continue

Started May 27, 2011

Green Baron Names Nuvilex Stock Pick of 2011

The Green Baron (www.thegreenbaron.com) announced after the closing bell yesterday that their 2011 Stock Pick of the Year is Nuvilex, Inc.(OTCQB:NVLX).…Continue

Tags: Cap, Small, Goldman, Research, price

Started May 24, 2011

"Personalized Medicine" Trend Shift Presents Opportunity for Device Manufacturers ($UNIS)

“A tectonic shift is taking place in medicine…” - Personalized Medicine Coalition…Continue

Tags: Science, for, Advisors, on, and

Started May 20, 2011

View All

Gifts Received

OTC Showcase has not received any gifts yet

Give a Gift

OTC Showcase's Page

Latest Activity

OTC Showcase posted a blog post

Cellceutix's Drug Discovery Is a Major Leap Forward in the Fight Against Cancer

Drug Delivery Devices Received From Hospital and Stability Studies Underway Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat unmet medical conditions, is pleased to report that the drug delivery devices for their planned clinical trials on Kevetrin™, the Company's revolutionary compound for the treatment of cancer, are undergoing stability studies. The research centers conducting the human…See More

Oct 3, 2011

0 Comments 0 Likes

OTC Showcase posted a blog post

Unilife CEO to purchase up to $1.0 Million in UNIS shares

CEO Alan Shortall intends to purchase additional U.S. $500,000 to $1.0 million in Unilife shares by September 30, 2011On July 15, 2011, a story at ProActive NewsRoom featured the short position in Unilife Corporation (NASDAQ:UNIS). The story was titled "Update on Unilife's Short Position" and it featured a number of reasons why UNIS was and is potentially a strong buy for investor. Positives listed in the article included:• Strong Insider Buying – CEO Alan Shortall amalgamates over a $20…See More

Aug 18, 2011

0 Comments 0 Likes

Kendawg replied to OTC Showcase's discussion Nuvilex Reports Positive Phase 2 Data for Pancreatic Cancer Treatment; $0.50 Price Target

"Thanks for the heads up Cash Cow.."

Jun 3, 2011

Cash Cow replied to OTC Showcase's discussion Nuvilex Reports Positive Phase 2 Data for Pancreatic Cancer Treatment; $0.50 Price Target

"I think it is really sad your trying to mislead traders into affiliating this rinky dink research firm with no legitimacy, going as far as to abbreviate the analyst promoters as Goldman. While most people have probably heard of Goldman Sachs, a few…"

Jun 3, 2011

OTC Showcase posted a discussion

Nuvilex Reports Positive Phase 2 Data for Pancreatic Cancer Treatment; $0.50 Price Target

Nuvilex (OTCQB:NVLX) recently announced favorable results of a completed Phase 2 clinical trial carried out in Europe to combat Pancreatic Cancer. The Company announced last week that it had acquired that the treatment technology which involves the use of encapsulated cells.The trial demonstrated both efficacy and an improvement in quality of life, due in large part to the reduction in toxicity levels from lower dose chemotherapy. Highlights of the trial, which were compared to Eli Lilly’s…See More

Jun 3, 2011

2 Comments

OTC Showcase posted a discussion

Misonix, Inc.: IP Award and New Targets of Opportunity

Misonix (NASDAQ: MSON; Stock Twits: $MSON) recently presented at the MDB Capital Bright Lights Conference in New York City -- the only conference of its kind with an exclusive focus on publicly-traded companies with market changing intellectual property (IP). Misonix was selected as one of 40 public companies out of 1,500 small-cap companies as a technological leader in the medical device field.Misonix is one of the few companies in the world that has an ability to apply ultrasound technology…See More

May 27, 2011

0 Comments

OTC Showcase posted a discussion

Green Baron Names Vuvilex Stock Pick of 2011

The Green Baron (www.thegreenbaron.com) announced after the closing bell yesterday that their 2011 Stock Pick of the Year is Nuvilex, Inc.(OTCQB:NVLX). Also interesting to note is a report issued by Goldman Research Group which has placed a near-term $0.50 price target on the up-and-coming biotech firm. The latest Green Baron Report gives takes an in-depth look at Nuvilex and offers commentary on why the Company is undervalued and poised to move. From…See More

May 24, 2011

0 Comments

OTC Showcase posted a discussion

"Personalized Medicine" Trend Shift Presents Opportunity for Device Manufacturers ($UNIS)

“A tectonic shift is taking place in medicine…” - Personalized Medicine Coalition"Genentech ... Pushing Data on Personalized Cancer Medicine" - xconomy.com"Is Business Intelligence The Key To Personalized Medicine?" - InformationWeek - Healthcare…See More

May 20, 2011

0 Comments

OTC Showcase posted a blog post

Nurses Have High Exposure to Needle/Syringe Safety Issues (Unilife Corp, NASDAQ:UNIS)

This week is National Nurses Week. Across the country, people are celebrating the work done by millions of nurses who provide care and treatment to patients. Nurses are amongst the most overworked, and arguably underpaid, of skilled professions in the U.S. They are also amongst the highest at risk of emotional stress or occupational harm. According to one recent survey by the American Nurses…See More

May 10, 2011

0 Comments 0 Likes

OTC Showcase posted discussions

Apr 9, 2011

OTC Showcase posted a discussion

Zack’s Notes Keryx ($KERX) Uptrend and 67% Change in 52 Weeks

Zacks.com, a leader in investment research, has aptly noted the recent uptrend in the share price of Keryx Biopharmaceuticals over the last several weeks. Zack’s “SmarTrend” analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.According to Zack’s commentary on April 5, 2011,“In the past 52 weeks, shares of Keryx Biopharmaceuticals have traded between a low of $3.03 and a high of $6.67 and are now at $5.05,…See More

Apr 7, 2011

0 Comments

OTC Showcase posted a discussion

The Cost of Diagnostics Versus the Cost of a Young Athlete’s Life

The title may have grabbed a reader’s attention and that was its purpose. All too often press releases that come from developmental companies are simply overlooked in the investment community as it doesn’t have a direct impact on today’s share price for the given company. Being an investor does not disassociate a person and their lives as a parent, relative, friend or even just an acquaintance to others; in short, a person. With that comes a freedom, and perhaps even an obligation, to speak…See More

Mar 18, 2011

0 Comments

OTC Showcase posted a discussion

Amico Games (AMCG) Video Stock Chart Analysis

The stock chart for Amico Games appears to be finding a bottom at this point. The moving averages have converged and the price per share is trading to the upper side of the bollinger bands which, combined with the lower indicators, that a stronger move may be coming. Technical traders are watching for the break of $0.04 resistance because the next resistance doesn't come into effect until 25% later at five cents and a possible move to the 200dma over $0.06. View the video chart at…See More

Feb 2, 2011

0 Comments

OTC Showcase posted a blog post

Industrial Nanotech (INTK.PK) Awarded Two New Projects

Industrial Nanotech, Inc. Enters Two New Municipal Markets - Wins Bid for City of San Jose Project in California and is Awarded Trial Project by Lafayette Consolidated Government in LouisianaIndustrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanotechnology based energy saving solutions, today announced that the Company has won the bidding process for a purchase contract by the City of San Jose in California to provide its patented Nansulate® Translucent GP insulation…See More

Feb 1, 2011

0 Comments 0 Likes

OTC Showcase replied to OTC Showcase's discussion Cellceutix Corporation (OTCBB: CTIX)

"Cellceutix Corporation Selects Destum Partners to Partner Psoriasis Compound BEVERLY, MA--(Marketwire - 07/26/10) - Cellceutix Corporation (OTC.BB:CTIX - News) is pleased to announce that it has selected Destum Partners to assist in finding a…"

Jul 26, 2010

OTC Showcase replied to OTC Showcase's discussion Cellceutix Corporation (OTCBB: CTIX)

"New development from their portfolio. Psoriasis compound is going to be marketed for development. The press release: http://finance.yahoo.com/news/Cellceutix-Corporation-iw-1645063166.html?x=0&.v=1 an article that I wrote on it (basically same…"

Jul 26, 2010

OTC Showcase's Blog

Cellceutix's Drug Discovery Is a Major Leap Forward in the Fight Against Cancer

Posted on October 3, 2011 at 9:31am 0 Comments 0 Likes

Drug Delivery Devices Received From Hospital and Stability Studies Underway

Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat unmet medical conditions, is pleased to report that the drug delivery devices for their planned clinical trials on Kevetrin™, the Company's revolutionary compound for the treatment of cancer, are undergoing stability studies. The…

Continue

Unilife CEO to purchase up to $1.0 Million in UNIS shares

Posted on August 18, 2011 at 10:33am 0 Comments 0 Likes

CEO Alan Shortall intends to purchase additional U.S. $500,000 to $1.0 million in Unilife shares by September 30, 2011

On July 15, 2011, a story at ProActive NewsRoom featured the short position in Unilife Corporation (NASDAQ:UNIS). The story was titled "Update on Unilife's Short Position" and it featured a number of reasons why UNIS was and is potentially a strong buy for investor. Positives listed in the article included:

• Strong Insider Buying – CEO Alan Shortall…

Continue

Nurses Have High Exposure to Needle/Syringe Safety Issues (Unilife Corp, NASDAQ:UNIS)

Posted on May 10, 2011 at 9:32pm 0 Comments 0 Likes

According to one recent survey by the…

Continue

Industrial Nanotech (INTK.PK) Awarded Two New Projects

Posted on February 1, 2011 at 11:45am 0 Comments 0 Likes

Industrial Nanotech, Inc. Enters Two New Municipal Markets - Wins Bid for City of San Jose Project in California and is Awarded Trial Project by Lafayette Consolidated Government in Louisiana

Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanotechnology based energy saving solutions, today announced that the Company has won the bidding process for a purchase contract by the City of San Jose in California to provide its patented Nansulate®…

Continue

Comment Wall

You need to be a member of Stocks To Buy Forum to add comments!

Join Stocks To Buy Forum

No comments yet!

Welcome to
Stocks To Buy Forum

Sign Up
or Sign In

Or sign in with:

Like Us on Facebook

Twitter

Follow @stockstobuy

Stock Alerts

- Subscribe Via RSS Feed or - Subscribe to Stocks To Buy by Email

Research

Hot Stocks - Today
Best Penny Stocks
Best Stocks 2012
Healthcare Stocks
Silver Stocks 2012
Stock Picks 2012
IPO Calendar

Buy Oil Stocks 2012/2013

What Stocks to Buy? Oil prices continue to rise and oil stocks are a good buy for the long term. For oil stock ideas, check out the latest hot shale plays in the US.

Utica Shale
Bakken Shale
Eagle Ford Shale

Niobrara Shale

Smackover Brown Dense
Tuscaloosa Marine Shale